BF
CLB icon

BOK Financial’s Core Laboratories CLB Stock Holding History

BOK Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,050
Closed -$584K – 979
2021
Q3 		$584K Buy
+21,050
New +$641K 0.01% 687
2020
Q1 		– Sell
-7,339
Closed -$276K – 843
2019
Q4 		$276K Sell
7,339
-394
-5% -$17.7K 0.01% 811
2019
Q3 		$361K Sell
7,733
-482
-6% -$22.4K 0.01% 746
2019
Q2 		$429K Sell
8,215
-1,209
-13% -$70.9K 0.01% 704
2019
Q1 		$650K Buy
9,424
+2,899
+44% +$194K 0.02% 604
2018
Q4 		$389K Sell
6,525
-862
-12% -$74.4K 0.01% 674
2018
Q3 		$856K Buy
7,387
+499
+7% +$56.3K 0.02% 532
2018
Q2 		$869K Buy
6,888
+72
+1% +$8.76K 0.02% 516
2018
Q1 		$738K Buy
6,816
+229
+3% +$25.3K 0.02% 536
2017
Q4 		$722K Sell
6,587
-288
-4% -$28.7K 0.02% 568
2017
Q3 		$679K Buy
6,875
+212
+3% +$20.6K 0.02% 579
2017
Q2 		$675K Buy
6,663
+853
+15% +$92K 0.02% 559
2017
Q1 		$671K Buy
5,810
+136
+2% +$15.8K 0.02% 577
2016
Q4 		$681K Buy
5,674
+875
+18% +$96.9K 0.02% 559
2016
Q3 		$539K Buy
4,799
+1,096
+30% +$126K 0.02% 620
2016
Q2 		$459K Sell
3,703
-69
-2% -$8.33K 0.02% 620
2016
Q1 		$424K Sell
3,772
-890
-19% -$92.5K 0.02% 616
2015
Q4 		$507K Buy
4,662
+1,731
+59% +$198K 0.02% 571
2015
Q3 		$292K Buy
2,931
+450
+18% +$48.9K 0.01% 695
2015
Q2 		$283K Buy
2,481
+491
+25% +$59.5K 0.01% 714
2015
Q1 		$208K Sell
1,990
-66
-3% -$7.03K 0.01% 769
2014
Q4 		$247K Sell
2,056
-813
-28% -$107K 0.01% 591
2014
Q3 		$420K Buy
2,869
+186
+7% +$28.7K 0.01% 610
2014
Q2 		$449K Buy
2,683
+226
+9% +$40.2K 0.01% 650
2014
Q1 		$487K Buy
2,457
+8
+0.3% +$1.51K 0.02% 632
2013
Q4 		$468K Buy
+2,449
New +$456K 0.02% 638

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

BOK Financial's CLB Position: Q4 2021 in Review

BOK Financial sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 21,050 shares — an estimated $584K sold.

BOK Financial first reported a position in CLB in Q4 2013 and held it in 26 quarters. The position peaked at $869K in Q2 2018. 173 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • BOK Financial reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
  • BOK Financial sold 21,050 Core Laboratories shares in Q4 2021, an estimated $584K.
  • BOK Financial first reported a position in Core Laboratories in Q4 2013 and held it in 26 quarters.
  • BOK Financial's Core Laboratories position peaked at $869K in Q2 2018.
  • 173 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on BOK Financial's 13F filing for Q4 2021, filed 11 Mar 2022.